[Interferon-alpha can improve the prognosis in high-risk melanoma. Combination of surgery, cytostatics and natural IFN-alpha doubled the survival rate]

Lakartidningen. 2008 Feb 6-12;105(6):358-61.
[Article in Swedish]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Combined Modality Therapy
  • Dacarbazine / therapeutic use*
  • Disease Progression
  • Humans
  • Immunologic Factors / therapeutic use*
  • Interferon-alpha / therapeutic use*
  • Melanoma / drug therapy
  • Melanoma / mortality
  • Melanoma / surgery
  • Melanoma / therapy*
  • Survival Rate
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Alkylating
  • Immunologic Factors
  • Interferon-alpha
  • Dacarbazine